3,000 breast cancer patients to reveal hidden toll of treatment

NCT ID NCT07010939

Recruiting now Knowledge-focused Sponsor: FangYi Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study follows 3,000 women with early-stage breast cancer to understand how local treatments like surgery and radiation affect their quality of life and cause side effects. Participants will complete surveys and undergo heart, lung, and blood tests over time. The goal is to find patterns and risk factors that could help future patients recover better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better predict and manage treatment side effects, improving quality of life for breast cancer survivors.
What could go wrong: This is an observational study, not a treatment trial. It will not directly change or improve care during the study period.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast disorder breast neoplasm invasive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST DISEASES BREAST NEOPLASMS QUALITY OF LIFE (QOL) TOXICITIES

Contacts and locations

Locations

Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center
ACTIVE_NOT_RECRUITING

Shenzhen, Guangdong, 518116, China
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
RECRUITING

Beijing, Beijing Municipality, 100021, China
Shanxi Cancer Hospital
ACTIVE_NOT_RECRUITING

Taiyuan, Shanxi, 030013, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.